BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Impacting Medicine with Microfluidics &amp\; Nanotechnology: Advan
 cing Diagnostics and Medicine - Professor Utkan Demirci\, Stanford Univers
 ity
DTSTART:20241115T140000Z
DTEND:20241115T150000Z
UID:TALK221218@talks.cam.ac.uk
CONTACT:46601
DESCRIPTION:Abstract\nMicro and nanoscale technologies can have a signific
 ant impact on medicine and biology in the areas of\ncell manipulation\, di
 agnostics and monitoring. At the convergence of these new technologies and
  biology\,\nwe research for enabling solutions to real-world problems at t
 he clinic. Emerging nanoscale and microfluidic\ntechnologies integrated wi
 th biology offer innovative possibilities for creating intelligent\, medic
 al\,\nmicrofluidic lab-chip devices that could transform diagnostics and m
 onitoring\, microrobotics\, tissue\nengineering and regenerative medicine.
  We will present interesting applications of microfluidic technologies\nin
  IVF\, applications of extracellular vesicles in cancer. \n\nShort Biograp
 hy\nDr. Utkan Demirci\, UofM’99\, Stanford’01’05’05\, is a Profess
 or of Radiology (with tenure) and of Electrical\nEngineering (by courtesy)
  at the Canary Center at Stanford for Cancer Early Detection\, Stanford Un
 iversity\nSchool of Medicine\, where he leads a productive researcher grou
 p. Dr. Utkan Demirci is a tenured professor\nat Stanford University School
  of Medicine. Prior to joining Stanford in 2014\, he held the position of 
 Associate\nProfessor at the Brigham and Women’s Hospital-Harvard Medical
  School and also served at the HarvardMIT Health Sciences and Technology d
 ivision. Over the past decade\, his research group is focused on the\nearl
 y detection of cancer and has made significant contributions to the develo
 pment of microfluidic platforms\nfor sorting rare cells and exosomes and p
 oint-of-care biosensing technologies. Utkan leads a productive and\nimpact
 ful research group focused on addressing problems from the clinic with inn
 ovations including cell\nsorter for IVF\, optical technologies for detecti
 ng viruses\, portable point of care technologies for diagnostics\nin globa
 l health\, smart robots in vivo\, extracellular vesicle based early detect
 ion approaches for cancer. He is\nan elected fellow of the American Instit
 ute of Medical and Biological Engineering and The Academy for\nRadiology &
  Biomedical Imaging Research Distinguished Investigator. He has published 
 over 250 peerreviewed articles\, 300 abstracts and proceedings\, 24 book c
 hapters and editorials\, and 7 edited books. He also\nserves on the editor
 ial board of various journals. He holds 15 patents (11 of which are transl
 ated into\nbiomedical products) and co-founded 5 companies. Dr. Demirci's 
 pioneering work in microfluidic cell sorting\nhas resulted in CE certified
  and FDA approved microfluidic devices used in over 500\,000 clinical case
 s and\nreadily accessible in over 1000+ IVF clinics serving patients globa
 lly
LOCATION:Oatley 1 Meeting Room\, Department of Engineering
END:VEVENT
END:VCALENDAR